It’s no surprise that the benefits of Extracorporeal Shockwave Therapy (ESWT) as a non-surgical way of treating a wide array of soft tissue conditions, is clearly becoming the most popular treatment.
“I began seeing Dr. Noel after my back became so painful I could barely function. As the therapy program progressed, my neck and back became more pain-free and looser...I am very thankful that after many years of suffering that my condition has improved considerably.” - GeneRead More...
Extracorporeal Shockwave Therapy (ESWT) is approved in the US by the Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. There is an FDA study to treat recalcitrant diabetic wounds. The FDA approved Storz Medical's Duolith SD1 -T-TOP device to administer ESWT.
The UK advisory body, the National Institute for Health and Care Excellence (NICE), have issued guidance on ESWT to UK clinicians for a number of clinical indications including calcific tendinitis of the shoulder, refractory plantar fascitiis, refractory Achilles tendinopathy, refractory tennis elbow, and refractory greater trochanteric pain syndrome.